Details for 2018182274

Up to date per 02.04.2026

Actions

Title / Product Name

GLUCAGON/GLP-1 AGONISTEN ZUR BEHANDLUNG VON OBESITÄT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018182274

EP Publication Number

3495380

E-Number

1478560

Language

PCT Number

Publication Date

12.06.2019 A

30.03.2022 B1

Registration Date

30.03.2022

AT Publication Date

15.04.2022

Application Date

10.12.2013

Registration Number

Priorities

11.12.2012

201261735823 P

IPC

A61K 38/00 20060101AFI20210311BHEP

Maximum Duration of Protection

10.12.2033

Owner

MedImmune LimitedMilstein Building Granta Park Cambridge Cambridgeshire CB21 6GHGB

Representative

Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

AGORAM, BalajiMilstein Building Granta Park Cambridge, CB21 6GHGB

ANTONSSON, Madeleinec/o AstraZeneca AB SE-151 85 SödertäljeSE

BEDNAREK, Maria, AMedImmune Limited Milstein Building, Granta Park Cambridge, Cambridgeshire CB21 6GHGB

BURMEISTER, NicoleMilstein Building Granta Park Cambridge, CB21 6GHGB

BENTHEM, Lambertusc/o AstraZeneca AB SE-151 85 SödertäljeSE

FAIRMAN, DavidMilstein Building Granta Park Cambridge, CB21 6GHGB

FRITSCH-FREDIN, Mariac/o AstraZeneca AB SE-151 85 SödertäljeSE

JACKSON, Ronald HenryMilstein Building Granta Park Cambridge, CB21 6GHGB

LOFMARK, Rasmus Janssonc/o AstraZeneca AB SE-151 85 SödertäljeSE

METCALFE, JaquelineMilstein Building Granta Park Cambridge, CB21 6GHGB

Information about Fees